Thrombomodulin activity on mesothelial cells: Perspectives for mesothelial cells as an alternative for endothelial cells for cell seeding on vascular grafts

British Journal of Haematology

Volumn 95, Issue 3, 1996, Pages 542-549

  Verhagen, H J M ^a   Heijnen Snyder, G J ^a   Pronk, A ^a   Vroom, Th M ^a   Van Vroonhoven, Th J M V ^a   Eikelboom, B C ^a   Sixma, J J ^a   De Groot, Ph G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Mesothelial cell seeding; Thrombomodulin; Vascular grafts

Indexed keywords

ACTIVATED PROTEIN C; THROMBOMODULIN;

ARTICLE; BLOOD VESSEL PROSTHESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MESOTHELIUM CELL; OMENTUM; PRIORITY JOURNAL;

EID: 0029967878     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1935.x     Document Type: Article

References (41)

1. Allaart, C.F., Poort, S.R., Rosendaal, F.R., Reitsma, P.H., Bertina, R.M. & Briët, E. (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet, 341, 134-138.
2. Anders, E., Alles, J.U., Delvos, U., Pötzsch, B., Preissner, K.T. & Müller-Berghaus, G. (1987) Microvascular endothelial cells from human omental tissue: modified method for long-term cultivation and new aspects of characterization. Microvascular Research, 34, 239-249.
3. Bertina, R.M., Koeleman, B.P., Koster, T., Rosendaal, F.R., Dirven, R.J., De Ronde, H., Van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
4. Budd, J.S., Allen, K.E., Bell, P.R.F. & James, R.F.L. (1990) The effect of varying fibronectin concentration on the attachment of endothelial cells to polytetrafluoroethylene vascular grafts. Journal of Vascular Surgery, 12, 126-130.
5. Bull, H.A., Pittilo, R.M., Drury, J., Pollock, J.G., Clarke, J.M.F., Woolf, N., Marston, A. & Machin, S.J. (1988) Effects of autologous mesothelial seeding on prostacyclin production within Dacron arterial prostheses. British Journal of Surgery, 75, 671-674.
6. Cho, J.S., Ouriel, K., DeWeese, J.A., Green, R.M., Chen, G.Y. & Stoughton, J. (1995) Thrombus formation on polytetrafluoroethylene surfaces: the importance of von Willebrand factor. Cardiovascular Surgery, 3, 645-651.
7. Clarke, J.M.F., Pittilo, R.M., Machin, S.J. & Woolf, N. (1984) A study of the possible role of mesothelium as a surface for flowing blood. Thrombosis and Haemostasis, 51, 57-60.
8. Collins, C.L., Ordonez, N.G., Schaefer, R., Cook, C.D., Xie, S.S., Granger, J., Hsu, P.L., Fink, L. & Hsu, S.M. (1992) Thrombo-modulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. American Journal of Pathology, 141, 827-833.
9. Esmon, N.L., Owen, W.G. & Esmon, C.T. (1982) Isolation of a membrane bound cofactor for thrombin-catalyzed activation of protein C. Journal of Biological Chemistry, 257, 859-864.
10. Esquivel, C.O. & Blaisdell, F.W. (1986) Why small caliber vascular grafts fail: a review of clinical and experimental experience and the significance of the interaction of the blood at the interface. Journal of Surgical Research, 41, 1-15.
11. Fulcher, C.A., Gardiner, J.H., Griffin, J.H. & Zimmerman, T.S. (1984) Proteolytic inactivation of human coagulation factor VIII procoagulant protein by activated human protein C and its analogy with factor Va. Blood, 63, 486-489.
12. Gimbrone, M.A. (1986) Vascular endothelium: nature's blood container. Vascular Endothelium in Hemostasis and Thrombosis (ed. by M. A. Gimbrone), pp. 1-13. Churchill Livingstone, Edinburgh.
13. Griffin, J., Evatt, B., Zimmerman, T., Kleiss, A. & Wideman, C. (1981) Deficiency of protein C in congenital thrombotic disease. Journal of Clinical Investigation, 68, 1370-1373.
14. Gruber, A., Griffin, J., Harker, L. & Hanson, S. (1989) Inhibition of platelet dependent thrombus formation by human activated protein C in a primate model. Blood, 73, 639-642.
15. Hanson, S.R., Griffin, J.H., Harker, L.A., Kelly, A.B., Esmon, Ch.T. & Gruber, A. (1993) Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. Journal of Clinical Investigation, 92, 2003-2013.
16. Herring, M., Dilley, R., Cullison, T., Gardner, A. & Glover, J. (1980) Seeding endothelium on canine arterial prostheses: the size of the inoculum. Journal of Surgical Research, 28, 35-38.
17. Houdijk, W.P.M., Sakariassen, K.S., Nievelstein, P.F.E.M. & Sixma, J.J. (1985) Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. Journal of Clinical Investigation, 75, 531-540.
18. Jaffe, E.A., Nachman, R.L., Becker, C.G. & Minick, C.R. (1973) Culture of human endothelial cells derived from umbilical cord veins: identification of morphology and immunologic criteria. Journal of Clinical Investigation, 52, 2745-2756.
19. Kempczinski, R.F., Rosenman, J.E., Pearce, W.H., Roedersheimer, L.R., Berlatzky, Y. & Ramalanjaona, G.R. (1985) Endothelial cell seeding of a new PTFE vascular prosthesis. Journal of Vascular Surgery, 2, 424-429.
20. Kisiel, W. (1979) Human plasma protein C: isolation, characterization and mechanism of activation by α-thrombin. Journal of Clinical Investigation, 64, 761-769.
21. Koedam, J.A., Meijers, J.C.M, Sixma, J.J. & Bouma, B.N. (1988) Inactivation of human factor VIII by activated protein C: cofactor activity of protein S and protective effect of von Willebrand factor. Journal of Clinical Investigation, 82, 1236-1243.
22. Menzies, D. & Ellis, H. (1990) Intestinal obstruction from adhesions: how big is the problem? Annals of the Royal College of Surgeons of England, 7, 60-63.
23. Michaels, J.A. (1989) Choice of materials for above-knee femoropopliteal bypass graft. British Journal of Surgery, 76, 7-14.
24. Moore, K.L., Andreoli, S.P., Esmon, N.L., Esmon, C.T. & Bang, N.U. (1987) Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. Journal of Clinical Investigation, 79, 124-130.
25. Moore, K.L., Esmon, C.T. & Esmon, N.L. (1989) Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood, 73, 159-165.
26. Oblath, R.W., Buckley, R.O., Green, R.M., Swartz, S.I. & De Weese, J.A. (1978) Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery, 84, 37-44.
27. Pronk, A., de Groot, Ph.G., Verbrugh, H.A., Leguit, P., van Vroonhoven, Th.J.M.V. & Sixma, J.J. (1992) Thrombogenicity and procoagulant activity of human mesothelial cells. Arteriosclerosis and Thrombosis, 12, 1428-2436.
28. Scarpati, E.M. & Sadler, E.M. (1989) Regulation of endothelial cell coagulant properties: modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. Journal of Biological Chemistry, 264, 20705-20713.
29. Schneeberger, P.M., Groenendaal, F., de Vries, L.S., van Loon, A.M. & Vroom T.M. (1994) Variable outcome of a congenital cytomegalovirus infection in a quadruplet after primary infection of the mother during pregnancy. Acta Paediatrica, 83, 986-989.
30. Szilagyi, D.E. (1982) Vascular substitutes: achievements, disappointment, prospects. Journal of Cardiovascular Surgery (Torino), 23, 183-193.
31. Thompson, J.N., Paterson-Brown, S., Harbourne, T., Whawell, S.A., Kalodiki, E. & Dudley, H.A.F. (1989) Reduced human peritoneal plasminogen activating activity: possible mechanism of adhesion formation. British Journal of Surgery, 76, 382-384.
32. Thompson, J.N. & Whawell, S.A. (1995) Pathogenesis and prevention of adhesion formation. British Journal of Surgery, 82, 3-5.
33. van Heerde, W.L., Poort, S., van 't Veer, C., Reutelingsberger, C.P.M. & de Groot, Ph.G. (1994) Binding of r-annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation. Biochemical Journal, 302, 305-312.
34. van Hinsbergh, V.W.M., Kooistra, T., Scheffer, M.A., van Bockel, J.H. & van Muijen, G.N.P. (1990) Characterization and fibrinolytic properties of human omental tissue mesothelial cells: comparison with endothelial cells. Blood, 75, 1490-1497.
35. Veith, F.J., Gupta, S.K., Ascer, E., White-Flores, S., Samson, R.H., Scher, L.A., Towne, J.B., Bernhard, V.M., Bonier, P. & Flinn, W.R. (1986) Six-year prospective multicentre randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. Journal of Vascular Surgery, 3, 104-114.
36. Verhagen, H.J.M. & Eikelboom, B.C. (1995) Cell seeding on synthetic vascular grafts: does it have a future? Critical Ischaemia, 4, 66-69.
37. Verhagen, H.J.M., Heijnen-Snyder, G.J., Pronk, A., Vink, T., Vroonhoven, Th.J.M.V., Sixma, J.J., Eikelboom, B.C. & Groot, Ph.G. (1995) Tissue factor expression on mesothelial cells is induced during in vitro culture: manipulation of culture conditions creates perspectives for mesothelial cells as a source for cell seeding procedures on vascular grafts. Thrombosis and Haemostasis, 74, 1096-1102.
38. Whitaker, D., Papadimitriou, J.M. & Walters, M. (1982) The mesothelium and its reactions: a review. Critical Reviews in Toxicology, 10, 81-144.
39. Willems, C., Astaldi, G., de Groot, Ph.G., Janssen, M.C., Gonsalvez, M.D., Zeijlemaker, W.P., Van Mourik, J.A. & Van Aken, W.G. (1982) Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. Experimental Cell Research, 139, 191-200.
40. Zilla, P., Deutsch, M., Meinhart, J.L., Puschmann, R., Eberl, T., Minar, E., Dudczak, R., Lugmaier, H., Schmidt, P., Noszian, I. & Fischlein, T. (1994) Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. Journal of Vascular Surgery, 19, 540-548.
41. Zwaginga, J.J., de Boer, H.C., Ijsseldijk, M.J.W., Kerkhof, A., Muller-Berghaus, G., Gruhlichhenn, J., Sixma, J.J. & de Groot, Ph.G. (1990) Thrombogenicity of vascular cells: comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. Arteriosclerosis and Thrombosis, 10, 437-448.